At Bionic Vision Australia, a consortium of researchers working on an eye prosthesis, the implantation of a bionic eye with 24 electrodes has turned out to be a success. A 54 year old female patient with vision loss due to retinitis pigmentosa had rece…
Category: News
Useful vision maintained long term after lens-sparing vitrectomy for ROP
Infants treated with lens-sparing vitrectomy for retinopathy of prematurity maintain a level of visual acuity necessary for useful vision into their eighth year of life, study results show.
Cataract Risk for Kids on Kalydeco for Cystic Fibrosis
Children taking Vertex Pharmaceuticals Inc’s cystic fibrosis pill Kalydeco (ivacaftor) may be at risk of getting cataracts, based on a study in juvenile rats. Reuters Health Information
Dry Eye Risk Similar After Laser Vision Surgeries
Two laser surgeries used to correct blurry vision have a similar chance of causing dry eyes, at least temporarily, a new study finds. Reuters Health Information
Cardiovascular Events in Diabetic Macular Edema
Why do cardiovascular complications often present in patients with serious eye diseases such as diabetic macular edema? This new study explains the connection. BMC Ophthalmology
Tips for parents to help their kids get a smart start to the academic year
The first day of school always requires preparations — notebooks, pens and a new set of clothes. But don’t forget to prepare for your child’s health, says Dr. Joan Bregstein, a physician in the Division of Pediatric Emergency Medicine at NewYork-Presb…
An Infant With Esotropia and a Cataract
What condition do you suspect is present in this 2-month-old girl with esotropia and a dense cataract in 1 eye? Medscape Ophthalmology
Adhesive May Improve Safety Of LASIK Eye Surgery
Kansas State University researchers have developed a glue mixture that may reduce risks after laser vision correction surgery. Stacy Littlechild, a recent bachelor’s degree graduate in biology originally from Wakeeney, is the lead author of two studies…
FDA Grants Orphan Drug Status to Gevokizumab
The FDA has granted orphan drug designation to gevokizumab for the treatment of noninfectious intermediate uveitis, posterior uveitis, or panuveitis, or chronic noninfectious anterior uveitis. Orphan Drug Approvals
Researchers develop glue mixture that may reduce risks after laser vision correction surgery
Kansas State University researchers have developed a glue mixture that may reduce risks after laser vision correction surgery.
To See or Not to See
Make sure your contact lens-wearing patients are aware of Acanthamoeba, a common but potentially serious eye infection, and how to prevent it. CDC Expert Commentary
Shedding New Light on a Potentially Blinding Eye Infection
Make sure your contact lens-wearing patients are aware of Acanthamoeba, a common but potentially serious eye infection, and how to prevent it. CDC Expert Commentary
FAQ: Decoding The $716 Billion In Medicare Reductions
The structure and financing of Medicare, the federal health insurance program that serves seniors and the disabled, has become a defining issue in the presidential and congressional campaigns since GOP presidential candidate Mitt Romney picked as his r…
River Blindness Research Looks At How The Parasite Thrives
Scientists at the University of Liverpool have found that the worm which causes River Blindness survives by using a bacterium to provide energy, as well as help ‘trick’ the body’s immune system into thinking it is fighting a different kind of infection…
How to Explain Medicare Reform to Your Patients
Mitt Romney’s selection of Rep. Paul Ryan (R-Wis.) as his running mate on the Republican ticket focuses new light on the congressman’s plan to restructure Medicare — the program that provides health care to 47 million elderly and disabled Americans. …
‘ESASO Course Series’ for ophthalmologists
In the new book series ‘ESASO Course Series’, the essentials of the courses of the European School for Advanced Studies in Ophthalmology (ESASO) are made available to interested ophthalmologists, optometrists, technicians and residents all over the world.
Mechanism Responsible For Eye Movement Disorder Identified
Discovery could lead to therapies for this condition, and a better understanding of how genetic mutations in the nervous system cause movement disorders in other parts of the body with a long term view to encouraging the re-growth of damaged cells A re…
Potential Target For Treatment Of Retinitis Pigmentosa
Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP). This groundbreaking study, led b…
Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases
Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the …
Study identifies mode of death of cone photoreceptor cells in animal model of RP
Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).